Start Tracking

Recent tweets for "#lungcancer"

#Lungcancer patients diagnosed in the early stages have a 20 year survival rate of 80%. But access to #screenings a… https://t.co/X3qvCtCMu0
3,243 followers     United States     Reply Retweet Favorite
RT @medical_xpress: Why #lungcancer doesn't respond well to immunotherapy @MIT @ImmunityCP https://t.co/HSWGe4dCuf https://t.co/bXNCJGERVS
144 followers     Paraguay     Reply Retweet Favorite
RT @OncoAlert: The #OncoAlertColloquium 🚨 3⃣,0⃣0⃣0⃣VIEWERS‼️ Day1⃣ #BreastCancer https://t.co/FHgVESaXZA Day2⃣GU Onc… https://t.co/O3RuF13rzW
5,406 followers     Miami, FL     Reply Retweet Favorite
RT @jillfeldman4: The @EGFRResisters and @LUNGevity are partnering again to fund more high-impact research to improve outcomes for pe… https://t.co/T1S43YAISp
1,600 followers     Jacksonville, FL     Reply Retweet Favorite
¡Mañana arranca la primera edición de Internacional Lung Cancer Debates! Los coordinadores científicos del… https://t.co/hbaSJQGggB
312 followers     Islas Canarias, España     Reply Retweet Favorite
🫁 Why doesn't #LungCancer respond well to #immunotherapy? Maria Zagorulya and a team in Dr. @StefaniSpranger's lab… https://t.co/5n0t9lLbhs
2,902 followers     Cambridge, MA     Reply Retweet Favorite
RT @SayaniAmbreen: Our equity-oriented lung cancer screening framework can be used by program implementers and decision-makers to guid… https://t.co/03TZxU3T0P
582 followers     Reply Retweet Favorite
#lungcancer missing in ratings from Google What percent of cancer is melanoma? Is breast cancer more common than… https://t.co/FeRmhOrUAS
12 followers     Reply Retweet Favorite
RT @OncoAlert: The #OncoAlertColloquium 🚨 3⃣,0⃣0⃣0⃣VIEWERS‼️ Day1⃣ #BreastCancer https://t.co/FHgVESaXZA Day2⃣GU Onc… https://t.co/BgHFBLuOdm
5,095 followers     United States     Reply Retweet Favorite
RT @OncoAlert: The #OncoAlertColloquium 🚨 3⃣,0⃣0⃣0⃣VIEWERS‼️ Day1⃣ #BreastCancer https://t.co/FHgVESaXZA Day2⃣GU Onc… https://t.co/wNYlxoEYVa
447 followers     Reply Retweet Favorite
Thanks @curetoday for highlighting our #lungcancer study, showing the importance of tracking treatment effectivenes… https://t.co/de2To8n4pB
3,008 followers     New Haven, CT     Reply Retweet Favorite
RT @CizzlePlc: https://t.co/ytd8HzwHUM In the next year about 50,000 UK men and women will face similar challenges. Only 1 in 10… https://t.co/ZQ4rXfiaoo
678 followers     Reply Retweet Favorite
RT @ColmBurkeTD: In last 7 days my sister Theresa lost her 6 year battle with #lungcancer. She was a Mercy Sister who worked in Keny… https://t.co/YTUJ8encUe
581 followers     Reply Retweet Favorite
RT @medical_xpress: Why #lungcancer doesn't respond well to immunotherapy @MIT @ImmunityCP https://t.co/HSWGe4dCuf https://t.co/bXNCJGERVS
363 followers     Reply Retweet Favorite
RT @EGFRResisters: February Newsletter is here! Check out the latest research updates, advocacy opportunities, and #lungcancer resourc… https://t.co/UPfsvudYmr
1,100 followers     California, USA     Reply Retweet Favorite
RT @jillfeldman4: The @EGFRResisters and @LUNGevity are partnering again to fund more high-impact research to improve outcomes for pe… https://t.co/T1S43YAISp
1,100 followers     California, USA     Reply Retweet Favorite
RT @medical_xpress: Why #lungcancer doesn't respond well to immunotherapy @MIT @ImmunityCP https://t.co/HSWGe4dCuf https://t.co/bXNCJGERVS
135 followers     日本     Reply Retweet Favorite
RT @OncoAlert: The #OncoAlertColloquium 🚨 3⃣,0⃣0⃣0⃣VIEWERS‼️ Day1⃣ #BreastCancer https://t.co/FHgVESaXZA Day2⃣GU Onc… https://t.co/BgHFBLuOdm
11,719 followers     Salt Lake City, UT     Reply Retweet Favorite
RT @CizzlePlc: This week Dame Esther Rantzen announced she has #lungcancer & is taking tests to decide on the best treatment. In h… https://t.co/JmeVsxXrvr
45 followers     N Wales     Reply Retweet Favorite
RT @medical_xpress: Why #lungcancer doesn't respond well to immunotherapy @MIT @ImmunityCP https://t.co/HSWGe4dCuf https://t.co/bXNCJGERVS
92 followers     Reply Retweet Favorite